Avitas Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,484
| Closed | -$405K | – | 218 |
|
|
2021
Q1 | $405K | Sell |
5,484
-1,093
| -17% | -$80.7K | 0.08% | 190 |
|
|
2020
Q4 | $461K | Buy |
6,577
+1,561
| +31% | +$109K | 0.09% | 189 |
|
|
2020
Q3 | $284K | Buy |
5,016
+25
| +0.5% | +$1.42K | 0.08% | 174 |
|
|
2020
Q2 | $291K | Sell |
4,991
-24
| -0.5% | -$1.4K | 0.1% | 154 |
|
|
2020
Q1 | $233K | Sell |
5,015
-1,494
| -23% | -$69.4K | 0.11% | 125 |
|
|
2019
Q4 | $364K | Sell |
6,509
-59
| -0.9% | -$3.3K | 0.09% | 154 |
|
|
2019
Q3 | $311K | Buy |
6,568
+2,444
| +59% | +$116K | 0.09% | 160 |
|
|
2019
Q2 | $221K | Buy |
4,124
+90
| +2% | +$4.82K | 0.06% | 162 |
|
|
2019
Q1 | $223K | Buy |
+4,034
| New | +$223K | 0.06% | 157 |
|